Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 Diabetes

Intradermal Microneedle Delivery of Insulin Lispro Achieves Faster Insulin Absorption and Insulin Action than Subcutaneous Injection

(2011) Ronald J. Pettis et al.   Diabetes Technology & Therapeutics

Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations

(2010) Michael A. Gibney et al.   CURRENT MEDICAL RESEARCH AND OPINION

Microneedle-Based Intradermal Delivery Enables Rapid Lymphatic Uptake and Distribution of Protein Drugs

(2010) Alfred J. Harvey et al.   PHARMACEUTICAL RESEARCH

From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

(2009) R. A. DeFronzo   DIABETES

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes

(2009) J. A. Davidson et al.   DIABETES CARE

Glucose Control and Cardiovascular Disease: Is it important? No

(2009) I. Conget et al.   DIABETES CARE

Minimally Invasive Insulin Delivery in Subjects with Type 1 Diabetes Using Hollow Microneedles

(2009) Jyoti Gupta et al.   Diabetes Technology & Therapeutics

Defining the Role of Insulin Lispro in??the Management of Postprandial Hyperglycaemia in Patients with Type??2 Diabetes Mellitus

(2008) D Giugliano et al.   CLINICAL DRUG INVESTIGATION